Expanding Access to Safe Water in Nigeria
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Elisa Maria Maffioli, PhD
- Phone Number: 4438754930
- Email: elisamaf@umich.edu
Study Locations
-
-
-
Kano, Nigeria
- Recruiting
- Kura, Dawakin Kudu, Kiru, and Rano LGAs
-
Contact:
- Gbenga Adedayo
- Phone Number: +234 805 602 6845
- Email: gadedayo@hanovialimited.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pregnant mothers and women with children under 5 children
Exclusion Criteria:
- Men, women with no children under 5 years old
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Treatment
Community Demonstrations and Redemption Points
|
Facilitators will collaborate with local leaders, WASH officials and health facility staff in conducting community demonstrations introducing the chlorine product (WaterGuard+) to communities in the treatment group.
Local leaders in the community will organize the meeting, while facilitators in the country will demonstrate how to use the product, what the correct dosage is, and explain the importance of water treatment.
They will also show how village water is contaminated with Ecoli.
These meetings will be targeted at eligible women (pregnant women and women with children under the age of 5), however all members of the community will be invited to attend.
At the meeting, each attendee will be given one bottle of WaterGuard+, which is enough to treat drinking water for a household of 5 members for about a month, and 1,000 naira.
Water Guard + is a 180g bottle of sodium dichloroisocyanurate (NaDCC) in granulated / powder form, produced and distributed by the Society for Family Health.
Study staff will set up at least one chlorine redemption point for each community.
The location of the redemption point will be determined in consultation with the local community during Community Demonstrations.
The redemption points could be health facilities, local shops/dispensaries/kiosks, local pharmacies, house of the village leader, CHW, or health staff or other suitable sites.
Households will be able to visit the location and redeem a month's supply of a chlorine product.
Distributors will use a redemption log to keep track of when participants redeem the chlorine product.
|
|
No Intervention: Control
Neither community distributions will be conducted nor redemption points will be set-up during the study period
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treat drinking water with chlorine (tested in water sample)
Time Frame: Measured up to 6 months of follow-up
|
Proportion of water samples with detectable chlorine in stored drinking water
|
Measured up to 6 months of follow-up
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treat drinking water with chlorine (self-reported)
Time Frame: Measured up to 6 months of follow-up
|
Proportion of women who reported using chlorine in the previous two days
|
Measured up to 6 months of follow-up
|
|
Presence of E.coli
Time Frame: Measured up to 6 months of follow-up
|
Proportion of water samples with detectable E.coli
|
Measured up to 6 months of follow-up
|
|
Level of E.coli
Time Frame: Measured up to 6 months of follow-up
|
Level of E-coli (in log10 MPN/100ml) in water samples
|
Measured up to 6 months of follow-up
|
|
Unsafe risk of Coliform
Time Frame: Measured up to 6 months of follow-up
|
Proportion of water samples with unsafe coliform ( >100 colony forming units per 100mL)
|
Measured up to 6 months of follow-up
|
|
Heard about chlorine
Time Frame: Measured up to 6 months of follow-up
|
Proportion of women who ever heard about chlorine
|
Measured up to 6 months of follow-up
|
|
Ever used chlorine
Time Frame: Measured up to 6 months of follow-up
|
Proportion of women who ever used chlorine
|
Measured up to 6 months of follow-up
|
|
Last used chlorine
Time Frame: Measured up to 6 months of follow-up
|
Proportion of women who used chlorine yesterday or the day before
|
Measured up to 6 months of follow-up
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Elisa Maria Maffioli, PhD, University of Michigan
- Principal Investigator: Pascaline Dupas, Princeton University
- Principal Investigator: Ana Radu, Princeton University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HUM00277959
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.